Business Day Guardian Health Latest Premium Times Rheumatoid Drug Baricitinib Uncategorized

Japan Approves Rheumatoid Drug Baricitinib for Covid-19 Patients

Japan’s health ministry approved on Friday the use of rheumatoid arthritis drug Baricitinib for COVID-19 patients, the third such approval following the drugs remdesivir and dexamethasone. Eli Lilly & Co’s